2023 Form 5500 filing — Takeda Pharmaceutical U.S.A., Inc. Savings And Retirement Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241011150713NAL0011081251001) for Takeda Pharmaceutical U.S.A., Inc. Savings And Retirement Plan, reported by Takeda Pharmaceutical U.S.A., Inc. under EIN 13-4013710 and plan number 001. It reports 35,272 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241011150713NAL0011081251001
Filing year
2023
Form type
2
Plan sponsor
Takeda Pharmaceutical U.S.A., Inc.
EIN
13-4013710
Plan number
001
Location
Cambridge, MA
Participants
35,272
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$5,471,853,608
Net assets (EOY)
$5,471,853,608
Employer contributions
$265,587,291
Participant contributions
$213,605,847
Total income / additions
$1,364,675,354
Benefits paid
$431,032,726
Administrative expenses
$2,463,676
Total expenses
$433,496,402
Net increase / (decrease)
$931,178,952
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Fidelity Inv Inst Ops Co., Inc.NONE$1,476,724$0
Strategic AdvisorsNONE$699,041not reported in the loaded dataset
Willis Towers Watson Us LLCNONE$253,325not reported in the loaded dataset
MercerNONE$98,862not reported in the loaded dataset
Forvis Mazars, LlpNONE$32,800not reported in the loaded dataset

Related Form 5500 pages